Related Experiment Video

Updated: Jun 26, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Clinical practice treatment of HIV infection in children

Bénédicte Brichard1, Dimitri Van der Linden

  • 1Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Avenue Hippocrate 10, 1200, Brussels, Belgium. Benedicte.Brichard@uclouvain.be

European Journal of Pediatrics
|January 20, 2009
PubMed

Insights

Pediatric HIV treatment is advancing, with aggressive antiretroviral therapy initiation crucial for infants. Guidelines now recommend combination drug regimens for children, considering age-specific needs and long-term complications.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Pharmacology

Background:

  • Perinatal transmission is the primary route of pediatric HIV infection.
  • Resource-rich countries have reduced mother-to-child HIV transmission through effective prevention and antiretroviral treatment.
  • Pediatric HIV treatment presents unique challenges including drug pharmacokinetics, drug availability, and adherence.

Purpose of the Study:

  • To provide general pediatricians with updated data and guidelines for treating HIV in children.
  • To highlight age-specific recommendations for initiating antiretroviral therapy in pediatric HIV cases.

Main Methods:

  • This is a review article summarizing recent pediatric HIV treatment data and guidelines.
  • Recommendations are based on international immunologic and clinical classification systems for HIV infection.
  • The review considers age-related differences in disease progression and treatment adherence.

Main Results:

  • Antiretroviral therapy initiation is more aggressive in children, especially infants, due to rapid disease progression.
  • Combination regimens of at least three drugs are currently recommended for pediatric HIV treatment.
  • Therapeutic strategies must account for potential long-term complications in children undergoing prolonged treatment.

Conclusions:

  • Aggressive and timely initiation of combination antiretroviral therapy is essential for managing pediatric HIV.
  • Treatment guidelines must be tailored to age, considering immunologic and clinical status.
  • Ongoing monitoring for long-term complications is critical for children with HIV.

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...